Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program ...Middle East

Study commences following green light from the U.S. FDA for Investigational New Drug Application HONG KONG, GERMANTOWN, Md. and SUZHOU, China, April 12, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"),...

Hence then, the article about sirnaomics launches phase i clinical trial for galnac factor xi program was published today ( Wednesday 12/04/2023 - 11:24 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program )

Also on site :

• ‘The Comeback’ Incited Public Confusion While Recreating 2023 Strikes Outside WB Lot: “Cars Were Honking”
• Gemini Space Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Gemini Space Station, Inc. - GEMI
• Noah Wyle tells hearing that 'The Pitt' shows TV and film production in the US can be revived